Chronic obstructive pulmonary disease in Hispanics A 9-Year update

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 1, 2018, Pages 15-21

  Díaz, Alejandro A ^a   Celli, Bartolomé ^a   Celedón, Juan C ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

AIR POLLUTION; BIOMASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DEMOGRAPHY; DISEASE BURDEN; GENETIC ANALYSIS; HEALTH CARE COST; HISPANIC; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SOCIAL DETERMINANTS OF HEALTH; SPIROMETRY; TOBACCO USE; AGED; ETHNOLOGY; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PREVALENCE; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 85039850639     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201708-1615PP     Document Type: Review

References (65)

1. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest 2013;143:1395–1406.
2. Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al.; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875–1881.
3. Brehm JM, Celedón JC. Chronic obstructive pulmonary disease in Hispanics. Am J Respir Crit Care Med 2008;177:473–478.
4. Chen W, Brehm JM, Boutaoui N, Soto-Quiros M, Avila L, Celli BR, et al. Native American ancestry, lung function, and COPD in Costa Ricans. Chest 2014;145:704–710.
5. United States Census Bureau. Quick facts United States [accessed 2017 Nov 27]. Available from: https://www.census.gov/quickfacts/fact/table/US/PST045216#qf-headnote-b.
6. Velasco-Mondragon E, Jimenez A, Palladino-Davis AG, Dawn D, Escamilla-Cejudo JA. Hispanic health in the U.S.A: a scoping review of the literature. Public Health Rev 2016:37.
7. Flores A, López G, Radford J. Facts on U.S. Latinos, 2015: statistical portrait of Hispanics in the United States. Washington, DC: Pew Research Center [accessed 2017 Nov 27]. Available from: http://www.pewhispanic.org/2017/09/18/facts-on-u-s-latinos-current-data/.
8. Dominguez K, Penman-Aguilar A, Chang MH, Moonesinghe R, Castellanos T, Rodriguez-Lainz A, et al.; Centers for Disease Control and Prevention (CDC). Vital signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States - 2009-2013. MMWR Morb Mortal Wkly Rep 2015;64:469–478.
9. LaVange L, Davis SM, Hankinson J, Enright P, Wilson R, Barr RG, et al. Spirometry reference equations from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Am J Respir Crit Care Med 2017;196:993–1003.
10. Conomos MP, Laurie CA, Stilp AM, Gogarten SM, McHugh CP, Nelson SC, et al. Genetic diversity and association studies in U.S. Hispanic/ Latino Populations: applications in the Hispanic Community Health Study/Study of Latinos. Am J Hum Genet 2016;98:165–184.
11. Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, Colangelo L, et al. Genetic ancestry in lung-function predictions. N Engl J Med 2010;363:321–330.
12. Tilert T, Dillon C, Paulose-Ram R, Hnizdo E, Doney B. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res 2013;14:103.
13. Barr RG, Avilés-Santa L, Davis SM, Aldrich TK, Gonzalez F II, Henderson AG, et al. pulmonary disease and age at immigration among Hispanics: results from the Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 2016;193:386–395.
14. Bruse S, Sood A, Petersen H, Liu Y, Leng S, Celedón JC, et al. New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med 2011;184:1254–1260.
15. Petersen H, Sood A, Meek PM, Shen X, Cheng Y, Belinsky SA, et al. Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest 2014;145:695–703.
16. Diaz AA, Come CE, Mannino DM, Pinto-Plata V, Divo MJ, Bigelow C, et al. Obstructive lung disease in Mexican Americans and non-Hispanic whites: an analysis of diagnosis and survival in the National Health and Nutritional Examination Survey III follow-up study. Chest 2014;145:282–289.
17. Powell R, Davidson D, Divers J, Manichaikul A, Carr JJ, Detrano R, et al. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study. Thorax 2013;68:634–642.
18. Powell R, Barr RG. Response letter to: the Hispanic paradox further unraveled? Thorax 2014;69:185–186.
19. Aldrich MC, Kumar R, Colangelo LA, Williams LK, Sen S, Kritchevsky SB, et al.; Health ABC and CARDIA Studies Groups. Genetic ancestry-smoking interactions and lung function in African Americans: a cohort study. Plos One 2012;7:e39541.
20. López Varela MV, Montes de Oca M, Rey A, Casas A, Stirbulov R, Di Boscio V; PUMA Team. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: the PUMA study. Respirology 2016;21:1227–1234.
21. Kinney GL, Thomas DS, Cicutto L, Newman LS, Lutz S, Hokanson JE. The protective effect of Hispanic ethnicity on chronic obstructive pulmonary disease mortality is mitigated by smoking behavior. J Pulm Respir Med 2014;4:220.
22. Menezes AM, Wehrmeister FC, Perez-Padilla R, Viana KP, Soares C, Müllerova H, et al. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017. Int J Chron Obstruct Pulmon Dis 2017;12:1491–1501.
23. Menezes AM, Pérez-Padilla R, Wehrmeister FC, Lopez-Varela MV, Muiño A, Valdivia G, et al.; PLATINO team. FEV1 is a better predictor of mortality than FVC: the PLATINO cohort study. Plos One 2014;9: e109732.
24. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults - United States, 2005-2015. MMWR Morb Mortal Wkly Rep 2016;65:1205–1211.
25. Kaplan RC, Bangdiwala SI, Barnhart JM, Castañeda SF, Gellman MD, Lee DJ, et al. Smoking among U.S. Hispanic/Latino adults: the Hispanic community health study/study of Latinos. Am J Prev Med 2014;46:496–506.
26. Lopez Varela MV, Montes de Oca M, Halbert RJ, Muiño A, Perez-Padilla R, Tálamo C, et al.; PLATINO Team. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010;36:1034–1041.
27. Singh T, Arrazola RA, Corey CG, Husten CG, Neff LJ, Homa DM, et al. Tobacco use among middle and high school students–United States, 2011-2015. MMWR Morb Mortal Wkly Rep 2016;65:361–367.
28. Anand V, McGinty KL, O’Brien K, Guenthner G, Hahn E, Martin CA. E-cigarette use and beliefs among urban public high school students in North Carolina. J Adolesc Health 2015;57:46–51.
29. Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief 2015;217:1–8.
30. Saddleson ML, Kozlowski LT, Giovino GA, Hawk LW, Murphy JM, MacLean MG, et al. Risky behaviors, e-cigarette use and susceptibility of use among college students. Drug Alcohol Depend 2015;149:25–30.
31. Littlefield AK, Gottlieb JC, Cohen LM, Trotter DR. Electronic cigarette use among college students: links to gender, race/ethnicity, smoking, and heavy drinking. J Am Coll Health 2015;63:523–529.
32. Webb Hooper M, Kolar SK. Racial/ethnic differences in electronic cigarette use and reasons for use among current and former smokers: findings from a community-based sample. Int J Environ Res Public Health 2016;13:E1009.
33. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al.; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:693–718.
34. Homa DM, Neff LJ, King BA, Caraballo RS, Bunnell RE, Babb SD, et al.; Centers for Disease Control and Prevention (CDC). Vital signs: disparities in nonsmokers’ exposure to secondhand smoke–United States, 1999-2012. MMWR Morb Mortal Wkly Rep 2015;64:103–108.
35. Manichaikul A, Hoffman EA, Smolonska J, Gao W, Cho MH, Baumhauer H, et al. Genome-wide study of percent emphysema on computed tomography in the general population: the Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med 2014;189:408–418.
36. Chen W, Brehm JM, Manichaikul A, Cho MH, Boutaoui N, Yan Q, et al. A genome-wide association study of chronic obstructive pulmonary disease in Hispanics. Ann Am Thorac Soc 2015;12:340–348.
37. Di Q, Wang Y, Zanobetti A, Wang Y, Koutrakis P, Choirat C, et al. Air pollution and mortality in the medicare population. N Engl J Med 2017;376:2513–2522.
38. Grineski SE, Herrera JM, Bulathsinhala P, Staniswalis JG. Is there a Hispanic health paradox in sensitivity to air pollution? Hospital admissions for asthma, chronic obstructive pulmonary disease and congestive heart failure associated with NO2 and PM2.5 in El Paso, TX, 2005-2010. Atmos Environ (1994) 2015;119:314–321.
39. Montes de Oca M, Zabert G, Moreno D, Laucho-Contreras ME, Lopez Varela MV, Surmont F. Smoke, biomass exposure, and COPD risk in the primary care setting: the PUMA study. Respir Care 2017;62: 1058–1066.
40. Diaz AA, Rahaghi FN, Doyle TJ, Young TP, Maclean ES, Martinez CH, et al. Differences in respiratory symptoms and lung structure between Hispanic and non-Hispanic white smokers: a comparative study. Chronic Obstr Pulm Dis 2017;4:297–304.
41. Hardie G, Liu R, Darden J, Gold WM. Ethnic differences in methacholine responsiveness and word descriptors in African Americans, Hispanic-Mexican Americans, Asian-Pacific Islanders, and Whites with mild asthma. J Asthma 2010;47:388–396.
42. Díaz AA, Morales A, Díaz JC, Ramos C, Klaassen J, Saldías F, et al. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. Respir Med 2013;107:570–579.
43. Mendoza L, Horta P, Espinoza J, Aguilera M, Balmaceda N, Castro A, et al. Pedometers to enhance physical activity in COPD: a randomised controlled trial. Eur Respir J 2015;45:347–354.
44. Martinez CH, Mannino DM, Jaimes FA, Curtis JL, Han MK, Hansel NN, et al. Undiagnosed obstructive lung disease in the United States: associated factors and long-term mortality. Ann Am Thorac Soc 2015;12:1788–1795.
45. Casas Herrera A, Montes de Oca M, López Varela MV, Aguirre C, Schiavi E, Jardim JR; PUMA Team. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries: a key to enhance disease diagnosis: the PUMA study. Plos One 2016;11:e0152266.
46. Montes de Oca M, Victorina Lopez Varela M, Laucho-Contreras ME, Casas A, Schiavi E, Mora JC. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study. BMC Pulm Med 2017;17:69.
47. Donohue KM, Hoffman EA, Baumhauer H, Guo J, Budoff M, Austin JH, et al. Cigarette smoking and airway wall thickness on CT scan in a multi-ethnic cohort: the MESA Lung Study. Respir Med 2012;106:1655–1664.
48. Díaz AA, Pinto-Plata V, Hernández C, Peña J, Ramos C, Díaz JC, et al. Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD. Respir Med 2015;109:882–889.
49. Tsai CL, Camargo CA Jr. Racial and ethnic differences in emergency care for acute exacerbation of chronic obstructive pulmonary disease. Acad Emerg Med 2009;16:108–115.
50. Martinez CH, Mannino DM, Curtis JL, Han MK, Diaz AA. Socioeconomic characteristics are major contributors to ethnic differences in health status in obstructive lung disease: an analysis of the National Health and Nutrition Examination Survey 2007-2010. Chest 2015;148:151–158.
51. Diaz AA, Petersen H, Meek P, Sood A, Celli B, Tesfaigzi Y. Differences in health-related quality of life between New Mexican Hispanic and Non-Hispanic white smokers. Chest 2016;150:869–876.
52. Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muiño A, et al.; PLATINO Team. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med 2009;103:1376–1382.
53. Trinidad DR, Pérez-Stable EJ, White MM, Emery SL, Messer K. A nationwide analysis of U.S. racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors. Am J Public Health 2011;101:699–706.
54. Levinson AH, Pérez-Stable EJ, Espinoza P, Flores ET, Byers TE. Latinos report less use of pharmaceutical aids when trying to quit smoking. Am J Prev Med 2004;26:105–111.
55. Straits-Tröster KA, Kahwati LC, Kinsinger LS, Orelien J, Burdick MB, Yevich SJ. Racial/ethnic differences in influenza vaccination in the Veterans Affairs Healthcare System. Am J Prev Med 2006;31:375–382.
56. Yoo BK, Hasebe T, Szilagyi PG. Decomposing racial/ethnic disparities in influenza vaccination among the elderly. Vaccine 2015;33: 2997–3002.
57. Egede LE, Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health 2003;93:2074–2078.
58. Montes de Oca M, Lopez Varela MV, Jardim J, Stirvulov R, Surmont F. Bronchodilator treatment for COPD in primary care of four Latin America countries: the multinational, cross-sectional, non-interventional PUMA study. Pulm Pharmacol Ther 2016;38:10–16.
59. Montes de Oca M, Tálamo C, Perez-Padilla R, Lopez MV, Muiño A, Jardim JR, et al.; PLATINO Team. Use of respiratory medication in five Latin American cities: the PLATINO study. Pulm Pharmacol Ther 2008;21:788–793.
60. Krauskopf K, Federman AD, Kale MS, Sigel KM, Martynenko M, O’Conor R, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD 2015;12:151–164.
61. The World Bank. GDP per capita (current US$) [accessed 2017 Nov 27]. Available from: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD.
62. The World Bank. Health expenditure per capita (current US$) [accessed 2017 Nov 27]. Available from: http://data.worldbank.org/indicator/SH.XPD.PCAP.
63. Pan American Health Organization. Schooling mean years [accessed 2017 Nov 27]. Available from: http://www.paho.org/data/index.php/en/indicators/demographics-core/357-schooling-en.html.
64. World Health Organization. Global Health Observatory data repository: tobacco use data by country [accessed 2017 Nov 27]. Available from: http://apps.who.int/gho/data/node.main.65.
65. World Health Organization. Global Health Observatory indicator views: population using solid fuels [accessed 2017 Nov 27]. Available from: http://apps.who.int/gho/data/node.imr.WHS5_512?lang=en.